Barclays Initiates Coverage On DexCom with Overweight Rating, Announces Price Target of $115

Benzinga Newsdesk www.benzinga.com Neutral 52.9%

Neg 0% Neu 52.9% Pos 0%

Barclays analyst Christopher Pasquale initiates coverage on DexCom (NASDAQ:DXCM) with a Overweight rating and announces Price Target of $115.